HEALWELL AI (TSE:AIDX)
TSX:AIDX
Want to see TSE:AIDX full AI Analyst Report?
AIDX Stock Chart & Stats
C$0.88
-C$0.19(-9.74%)
At close: 4:00 PM EST
C$0.88
-C$0.19(-9.74%)
Day’s Range― - ―
52-Week RangeC$0.58 - C$1.64
Previous CloseN/A
Volume682.92K
Average Volume (3M)459.97K
Market Cap
C$263.74M
Enterprise ValueC$313.38M
Total Cash (Recent Filing)C$21.95M
Total Debt (Recent Filing)C$86.73M
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Aug 17, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding303,043,800
10 Day Avg. Volume558,932
30 Day Avg. Volume459,971
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.70
Price to Sales (P/S)2.03
P/FCF Ratio-10.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.46Price Target Upside179.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.08
Revenue Forecast (FY)C$136.78M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained TTM revenue growth of ~16% indicates durable demand and product-market fit in healthcare AI. A growing revenue base supports scaling of sales/engineering investments and provides the structural foundation needed to absorb fixed costs and move toward operating leverage over months.
Gross Margin ImprovementMargin expansion from ~17% to ~45% TTM reflects material improvement in unit economics and/or pricing power. Higher gross margins create durable capacity to fund SG&A and R&D from revenue, improving the path to sustainable profitability as scale increases.
Improved Leverage / CapitalizationReduction of leverage to roughly 0.69 from prior >1.4 levels materially lowers refinancing and solvency risk. A more moderate debt profile preserves balance-sheet flexibility to fund growth or weather setbacks over the medium term without immediate liquidity stress.
Bears Say
Persistent UnprofitabilityDeep negative margins and losses across EBITDA/EBIT/net income show the business has not yet converted revenue scale into operating profitability. Persisting losses erode equity, limit self-funding of growth, and raise the bar for sustainable shareholder returns absent structural margin improvements.
Weak Cash GenerationNegative operating and free cash flow (~-$10M to -$12M TTM) indicate ongoing cash burn and reliance on external financing. This constrains strategic optionality, heightens dilution risk if capital markets tighten, and limits the company's ability to invest sustainably in sales or R&D.
Negative Returns On EquityA TTM ROE near -39% signals equity value erosion from continued losses. Structural negative returns reduce investor capital incentives, can impair future fundraising terms, and pose a persistent governance and strategic risk until profitability is restored.
HEALWELL AI News
AIDX FAQ
What was HEALWELL AI’s price range in the past 12 months?
HEALWELL AI lowest stock price was C$0.58 and its highest was C$1.64 in the past 12 months.
What is HEALWELL AI’s market cap?
HEALWELL AI’s market cap is C$263.74M.
When is HEALWELL AI’s upcoming earnings report date?
HEALWELL AI’s upcoming earnings report date is Aug 17, 2026 which is in 49 days.
How were HEALWELL AI’s earnings last quarter?
HEALWELL AI released its earnings results on May 07, 2026. The company reported -C$0.02 earnings per share for the quarter, missing the consensus estimate of -C$0.019 by -C$0.001.
Is HEALWELL AI overvalued?
According to Wall Street analysts HEALWELL AI’s price is currently Undervalued.
Does HEALWELL AI pay dividends?
HEALWELL AI does not currently pay dividends.
What is HEALWELL AI’s EPS estimate?
HEALWELL AI’s EPS estimate is -0.02.
How many shares outstanding does HEALWELL AI have?
HEALWELL AI has 303,043,800 shares outstanding.
What happened to HEALWELL AI’s price movement after its last earnings report?
HEALWELL AI reported an EPS of -C$0.02 in its last earnings report, missing expectations of -C$0.019. Following the earnings report the stock price went up 1.053%.
Which hedge fund is a major shareholder of HEALWELL AI?
Currently, no hedge funds are holding shares in TSE:AIDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HEALWELL AI Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$2.46 (179.36% Upside)
C$2.46 (179.36% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.1%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.00%
12-Months-Change
Fundamentals
Return on Equity
-31.80%
Trailing 12-Months
Asset Growth
26.03%
Trailing 12-Months
Company Description
HEALWELL AI
Healwell AI Inc., a Toronto-based healthcare technology firm established in 2012, specializes in leveraging artificial intelligence and data science to advance preventative medical care. The company develops an AI-powered platform designed to assist healthcare providers with crucial decision-making. They maintain a significant strategic partnership with WELL Health Technologies Corp., focusing on accelerating the expansion and innovation of AI-driven healthcare solutions. Prior to its current name, adopted in October 2023, the organization was known as MCI Onehealth Technologies Inc.
AIDX Stock 12 Month Forecast
Average Price Target
C$2.46
▲(179.36% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
Leveljump Healthcare Corp.
―
Kovo HealthTech Corporation
―
Hydreight Technologies Inc
―
Options Prices
Currently, No data available
---